日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pretreatment MRI radiomics for predicting pathological Miller-Payne grading in breast cancer following neoadjuvant chemotherapy

新辅助化疗后乳腺癌病理学Miller-Payne分级预测的治疗前MRI放射组学

Bi, Chengliu; Chen, Ao; Ran, Fengming; Hu, Zaoxiu; Sun, Shaomei; Wang, Ruolan; Niu, Xiaofeng; Deng, Lijuan; Gao, Depei; Li, Qinqing; Yang, Jun

Impact of marital disparities in treatment and outcome in elderly patients with T1N0M0 small cell lung cancer

婚姻状况差异对老年T1N0M0期小细胞肺癌患者治疗和预后的影响

Wu, Yahua; Zhu, Yingjiao; Lu, Lihu; Du, Bin; Jiang, Rongqi; Zheng, Jianping; Hong, Yaping; Lv, Chengliu; Yao, Na; Lai, Jinhuo

Design, synthesis and structure-activity relationship analysis of dibenzodiazepinone derivatives against Osimertinib resistant NSCLC

二苯并二氮杂卓酮衍生物抗奥希替尼耐药性非小细胞肺癌的设计、合成及构效关系分析

Jin, Chengliu; Zhang, Zhen; Liao, Peng; Zhang, Chen; Cao, Hua; Ma, Yan-Long

A study on the classification and prediction of firefighter's operational fatigue level

消防员作业疲劳程度分类与预测研究

Xu, Mingwei; Yang, Shangxue; Wang, Ke; Yu, Chengliu; Liu, Guanlin; Dai, Chao; Wang, Ruiqi

Efficacy and safety of PD-1 inhibitors plus chemotherapy with or without endostatin for stage IV lung squamous cancer: a retrospective study

PD-1抑制剂联合化疗(含或不含内皮抑素)治疗IV期肺鳞癌的疗效和安全性:一项回顾性研究

Lv, Chengliu; Wu, Yahua; Gu, Weiwei; Du, Bin; Yao, Na; Zhu, Yingjiao; Zheng, Jianping; Hong, Yaping; Lai, Jinhuo

Ribosomal protein L22 like 1: a promising biomarker for lung adenocarcinoma

核糖体蛋白 L22 样 1:一种有希望的肺腺癌生物标志物

Yahua Wu, Na Yao, Bin Du, Yingjiao Zhu, Xiaohui Ji, Chengliu Lv, Jinhuo Lai

Impact of the number of lymph node dissections and a novel risk stratification on the prognosis in elderly locally advanced esophageal adenocarcinoma

淋巴结清扫次数及新型风险分层对老年局部晚期食管腺癌预后的影响

Wu, Yahua; Gu, Weiwei; Du, Bin; Lv, Chengliu; Yao, Na; Zhu, Yingjiao; Ouyang, Jingxiang; Lai, Jinhuo

Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy

一种用于预测接受抗PD-1联合化疗(伴或不伴抗血管生成治疗)的晚期非小细胞肺癌患者生存期的新型列线图

Wu, Yahua; Lv, Chengliu; Lin, Mingqian; Hong, Yaping; Du, Bin; Yao, Na; Zhu, Yingjiao; Ji, Xiaohui; Li, Jiancheng; Lai, Jinhuo

The identification of genes associated T-cell exhaustion and construction of prognostic signature to predict immunotherapy response in lung adenocarcinoma

鉴定与T细胞耗竭相关的基因并构建预后特征以预测肺腺癌的免疫治疗反应

Wu, Yahua; Du, Bin; Lin, Mingqiang; Ji, Xiaohui; Lv, Chengliu; Lai, Jinhuo

First-generation EGFR-TKI plus bevacizumab and chemotherapy for advanced EGFR-mutated non-squamous non-small-cell lung cancer: a retrospective study

第一代 EGFR-TKI 联合贝伐珠单抗和化疗治疗晚期 EGFR 突变型非鳞状非小细胞肺癌:一项回顾性研究

Wu, Yahua; Du, Bin; Lv, Chengliu; Ji, Xiaohui; Lan, Yanqin; Yao, Na; Zhu, Yingjiao; Lai, Jinhuo